GLP-1

Microdosing semaglutide is gaining traction as a lower-side-effect weight loss strategy, but here's what the actual dose-response evidence…

AI-driven prescription monitoring systems are changing how GLP-1 medications are managed — here's what the science says about…

Clinical trials show semaglutide users lose an average of 10–17% of body weight, but real-world results vary widely…

BMI is the most widely used health metric in clinical medicine, but research consistently shows it fails to…

GLP-1 medications can cause significant muscle loss equivalent to 20 years of aging — here's what the latest…

Ozempic can produce weight loss without deliberate dieting, but research shows that skipping nutrition and training leads to…

Oral tirzepatide pills are not yet FDA-approved, but the science behind oral GLP-1 therapy is advancing fast —…

The STEP 1 trial showed nearly 15% body weight loss at 2.4 mg weekly — here is what…

New 2024 data shows nearly half of GLP-1 users drop off within six months — and the biggest…

A comprehensive, research-backed guide to using Ozempic injections correctly — covering pen technique, dose escalation, side effect management,…